Alkermes plcの収益Y / Y

Alkermes plcの収益Y / Yは何ですか。

Alkermes plcの収益Y / Yは3.14%です。

収益Y / Yの定義は何ですか。

過去3年間の年間収益の伸びは、過去3年間で平均した1年間の収益成長率です。

The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.

NASDAQのセクタHealth Careにおける収益Y / Yの企業と比べるAlkermes plc

Alkermes plcは何をしますか。

alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.

Alkermes plcと類似の収益y / y